Balance Sheet Components (Tables)

9 Months Ended

Sep. 30, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of property and equipment, net

Property and equipment, net consisted of the following:

	As of September 30, 2023		As of December 31, 2022
Building and land	$	11,728	$	11,728
Leasehold improvements	680		569
Computer hardware and software	780		780
Office and lab equipment	9,148		5,501
Furniture and fixtures	1,491		1,202
	$	23,827	$	19,780
Accumulated depreciation	(7,335)		(4,914)
	16,492		14,866
Equipment not yet in service	1,177		2,646
Property and equipment, net	$	17,669	$	17,512

Schedule of other noncurrent assets

Other non-current assets consisted of the following:

	As of September 30, 2023		As of December 31, 2022
Operating lease right-of-use assets	$	32,330	$	34,928
Other	2,377		2,585
Other non-current assets	$	34,707	$	37,513

Schedule of accrued expenses and other current liabilities

Accrued expenses and other current liabilities consisted of the following:

	As of September 30, 2023		As of December 31, 2022
Accrued employee compensation and benefits	$	13,977	$	14,603
Accrued clinical trial costs	27,945		17,788
Operating lease liability - current portion	3,281		3,019
Other accrued expenses and other current liabilities	7,431		8,696
Accrued expenses and other current liabilities	$	52,634	$	44,106